NK

Wei Wen1,2, Xiang Chen3, Xin-Yi Shen4

  • 1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.

PubMed
概括

优化自然杀手 (NK) 细胞从造血干细胞和前代细胞 (HSPCs) 使用高透显著提高效率的生产. 这一突破使得用于癌症免疫治疗的高收益NK细胞疗法具有成本效益.